Persistent Identifier
|
doi:10.17617/3.PWPUU0 |
Publication Date
|
2024-09-13 |
Title
| Dormancy-inducing 3D-engineered matrix uncovers mechanosensitive and drug protective FHL2-p21 signaling axis |
Author
| Bakhshandeh, Sadra
Department of Biomaterials, Max Planck Institute of Colloids and Interfaces
Heras Manterola, Unai
Group of Bioengineering in Regeneration and Cancer, Biogipuzkoa Health Research Institute
Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country
Taïeb, Dr. Hubert Mordehaï
Department of Biomaterials, Max Planck Institute of Colloids and Interfaces
Varadarajan, Adithi Ravikumar
Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine
Lissek, Susanna M.
Experimental Medicine and Therapy Research, University of Regensburg
Hücker, Sarah
Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine
Lu, Xin
Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine
Garske, Daniela
Department of Biomaterials, Max Planck Institute of Colloids and Interfaces
Young, Sarah A. E.
Department of Biomaterials, Max Planck Institute of Colloids and Interfaces
Abaurrea, Andrea
Group of Breast Cancer, Biogipuzkoa Health Research Institute
Caffarel, Maria
Group of Breast Cancer, Biogipuzkoa Health Research Institute
Ikerbasque
Riestra, Ana Cristina
Department of Pharmacy, Fundación Onkologikoa Fundazioa
Deparmtent of Medicine, University of Deusto
Bragado Domingo, Paloma
Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Universidad Complutense de Madrid
Health Research Institute, Hospital Clínico San Carlos
Contzen, Jörg
Department of Experimental Neurology, Charité - Universitätsmedizin Berlin
Institute of Active Polymers, Helmholtz-Zentrum Hereon
Berlin-Brandenburger Centrum für Regenerative Therapien
Gossen, Manfred
Institute of Active Polymers, Helmholtz-Zentrum Hereon
Kirsch, Stefan
Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine
Warfsmann, Jens
Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine
Honarnejad, Kamran
Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine
Klein, Christoph A.
Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine
Experimental Medicine and Therapy Research, University of Regensburg
Cipitria, Dr. Amaia
Department of Biomaterials, Max Planck Institute of Colloids and Interfaces
Groupo of Bioengineering in Regenaration and Cancer, Biodonostia Health Research Institute San Sebastian
IKERBASQUE, Basque Foundation for Science Bilbao
|
Description
| Resected tumors frequently relapse with distant metastasis, despite systemic treatment. Cellular dormancy has been identified as an important mechanism underlying such drug resistance enabling late relapse. Nonetheless, hurdles associated with detection and isolation of disseminated cancer cells (DCCs) in disease-free patients urge the need for in vitro models of dormant cells suited for drug discovery. Here, we explore dormancy-inducing 3D-engineered matrices, which generate mechanical confinement and induce growth arrest and survival against chemotherapy in cancer cells. We characterized the dormant phenotype of solitary cells by P-ERKlow:P-p38high dormancy signaling ratio, along with Ki67- expression. As underlying mechanism, we identified stiffness-dependent nuclear localization of the four-and-a-half LIM domains 2 (FHL2) protein, leading to p53-independent high p21Cip1/Waf1 nuclear expression, validated in murine and human tissue. Suggestive of a resistance-causing role, cells in the dormancy-inducing matrix became sensitive against chemotherapy upon FHL2 downregulation. Thus, our biomaterial-based approach will enable systematic screens for novel compounds suited to eradicate potentially relapsing, dormant cancer cells. |
Depositor
| Bibliothek MPIKG, n/a |
Deposit Date
| 2024-04-19 |